ENAMEX ID="NYU_ENAMEX617" TYPE="ORGANIZATION" START="141" END="162" TEXT="evidence review group"
ENAMEX ID="NYU_ENAMEX616" TYPE="ORGANIZATION" START="164" END="167" TEXT="ERG"
RELATION ID="NYU_RELATION618" TYPE="ABBREVIATE" START="141" END="167" ARG1="NYU_ENAMEX617" ARG1_NAME="FULLNAME" ARG2="NYU_ENAMEX616" ARG2_NAME="SHORTNAME" ARG1_TEXT="evidence review group" ARG2_TEXT="ERG" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON620" START="465" END="492" TEXT="single technology appraisal"
JARGON ID="NYU_JARGON619" START="494" END="497" TEXT="STA"
RELATION ID="NYU_RELATION621" TYPE="ABBREVIATE" START="465" END="497" ARG1="NYU_JARGON620" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON619" ARG2_NAME="SHORTNAME" ARG1_TEXT="single technology appraisal" ARG2_TEXT="STA" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON623" START="577" END="604" TEXT="randomised controlled trial"
JARGON ID="NYU_JARGON622" START="606" END="609" TEXT="RCT"
RELATION ID="NYU_RELATION624" TYPE="ABBREVIATE" START="577" END="609" ARG1="NYU_JARGON623" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON622" ARG2_NAME="SHORTNAME" ARG1_TEXT="randomised controlled trial" ARG2_TEXT="RCT" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON626" START="722" END="732" TEXT="cetuximab "
JARGON ID="NYU_JARGON625" START="751" END="754" TEXT="CTX"
RELATION ID="NYU_RELATION627" TYPE="ABBREVIATE" START="722" END="754" ARG1="NYU_JARGON626" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON625" ARG2_NAME="SHORTNAME" ARG1_TEXT="cetuximab " ARG2_TEXT="CTX" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON629" START="950" END="975" TEXT="progression-free survival"
JARGON ID="NYU_JARGON628" START="977" END="980" TEXT="PFS"
RELATION ID="NYU_RELATION630" TYPE="ABBREVIATE" START="950" END="980" ARG1="NYU_JARGON629" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON628" ARG2_NAME="SHORTNAME" ARG1_TEXT="progression-free survival" ARG2_TEXT="PFS" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON632" START="1691" END="1727" TEXT="incremental cost-effectiveness ratio"
JARGON ID="NYU_JARGON631" START="1729" END="1733" TEXT="ICER"
RELATION ID="NYU_RELATION633" TYPE="ABBREVIATE" START="1691" END="1733" ARG1="NYU_JARGON632" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON631" ARG2_NAME="SHORTNAME" ARG1_TEXT="incremental cost-effectiveness ratio" ARG2_TEXT="ICER" GRAM_SIGNAL="PARENTHESES"
JARGON ID="NYU_JARGON635" START="1757" END="1783" TEXT="quality-adjusted life-year"
JARGON ID="NYU_JARGON634" START="1785" END="1789" TEXT="QALY"
RELATION ID="NYU_RELATION636" TYPE="ABBREVIATE" START="1757" END="1789" ARG1="NYU_JARGON635" ARG1_NAME="FULLNAME" ARG2="NYU_JARGON634" ARG2_NAME="SHORTNAME" ARG1_TEXT="quality-adjusted life-year" ARG2_TEXT="QALY" GRAM_SIGNAL="PARENTHESES"
